Across TCGA pan-cancer cohorts, MIR1208 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of MIR1208’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where MIR1208 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR1208 is over-expressed in tumor.
KIRC, BRCA, and LUSC are the cancer types where MIR1208 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR1208 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.